Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Thrombocytopenia Purpura”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Post-approval studies (Phase 4)UnknownNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Testing effectiveness (Phase 2)WithdrawnNCT04039477
What this trial is testing

Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Who this might be right for
Autoimmune Hemolytic AnemiaImmune Thrombocytopenia
Kezar Life Sciences, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Not applicableNot Yet RecruitingNCT07268898
What this trial is testing

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 500
Early research (Phase 1)Study completedNCT03603132
What this trial is testing

Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 15
Not applicableNot Yet RecruitingNCT06873672
What this trial is testing

Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China

Who this might be right for
Quality of Life (QOL)Patient-Reported Outcome Measures (PROMs)Pneumonia Childhood+3 more
RenJi Hospital 360
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Large-scale testing (Phase 3)Study completedNCT00504075
What this trial is testing

Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic Purpura
Bio Products Laboratory 35
Testing effectiveness (Phase 2)Study completedNCT00621894
What this trial is testing

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Who this might be right for
Immune Thrombocytopenic Purpura
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Study completedNCT00049725
What this trial is testing

Daclizumab to Treat Chronic Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
National Institutes of Health Clinical Center (CC) 24
Post-approval studies (Phase 4)Study completedNCT01957176
What this trial is testing

A Rollover Study to Provide Continued Treatment With Eltrombopag

Who this might be right for
Thrombocytopaenia
Novartis Pharmaceuticals 22
Not applicableWithdrawnNCT01869049
What this trial is testing

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University
Not applicableStudy completedNCT00454857
What this trial is testing

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)+1 more
Amgen 326
Large-scale testing (Phase 3)Study completedNCT00749112
What this trial is testing

Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias

Who this might be right for
Idiopathic Thrombocytopenic PurpuraAnemia, Hemolytic, Autoimmune
Hospital Universitario Dr. Jose E. Gonzalez 19
Testing effectiveness (Phase 2)UnknownNCT02834286
What this trial is testing

Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Hospital Universitario Dr. Jose E. Gonzalez 15
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Large-scale testing (Phase 3)Study completedNCT00508820
What this trial is testing

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

Who this might be right for
Idiopathic Thrombocytopenic PurpuraThrombocytopeniaThrombocytopenic Purpura
Amgen 407
Load More Results